Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RGP Contact Lens Lubricating Drops, specifically the formulation developed by Bausch + Lomb, is a sterile ophthalmic solution designed for the lubrication and rewetting of rigid gas permeable (RGP) contact lenses. The solution is intended for direct application to the eye while lenses are being worn to alleviate dryness, discomfort, and minor irritation associated with lens wear. It functions by coating the lens surface with a hydrophilic film, which reduces friction between the lens and the ocular surface and helps to clear away debris. Common ingredients in Bausch + Lomb's RGP lubricants, such as the Boston product line, include viscosity-enhancing agents like hydroxyethyl cellulose and surfactants like polyvinyl alcohol that maintain a stable tear film. In various jurisdictions, including China, these products are regulated as medical devices.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on RGP contact lens lubricating drops.